Bristol Myers Loses EU Patent For Cancer Antibodies
European officials have revoked a Bristol Myers Squibb patent for antibodies that help fight cancer because other scientists would have also focused on a unique feature of a protein that suppresses...To view the full article, register now.
Already a subscriber? Click here to view full article